ARBB vs. DOCS, WIX, CNIC, YOU, NET, SRAD, SLP, GVP, CYN, and INSE
Should you be buying Arbuthnot Banking Group stock or one of its competitors? The main competitors of Arbuthnot Banking Group include Dr. Martens (DOCS), Wickes Group (WIX), CentralNic Group (CNIC), YouGov (YOU), Netcall (NET), Stelrad Group (SRAD), Sylvania Platinum (SLP), Gabelli Value Plus+ Trust (GVP), CQS Natural Resources Growth and Income (CYN), and Inspired (INSE). These companies are all part of the "computer software" industry.
Arbuthnot Banking Group vs.
Dr. Martens (LON:DOCS) and Arbuthnot Banking Group (LON:ARBB) are both small-cap consumer cyclical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, community ranking, earnings and risk.
Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 5.7%. Arbuthnot Banking Group pays an annual dividend of GBX 47 per share and has a dividend yield of 5.0%. Dr. Martens pays out 42.5% of its earnings in the form of a dividend. Arbuthnot Banking Group pays out 24.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
In the previous week, Dr. Martens had 6 more articles in the media than Arbuthnot Banking Group. MarketBeat recorded 6 mentions for Dr. Martens and 0 mentions for Arbuthnot Banking Group. Dr. Martens' average media sentiment score of 0.45 beat Arbuthnot Banking Group's score of 0.00 indicating that Dr. Martens is being referred to more favorably in the media.
Arbuthnot Banking Group has a net margin of 12.76% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 18.91% beat Arbuthnot Banking Group's return on equity.
Dr. Martens has a beta of 0.11, suggesting that its stock price is 89% less volatile than the S&P 500. Comparatively, Arbuthnot Banking Group has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.
69.5% of Dr. Martens shares are held by institutional investors. Comparatively, 20.0% of Arbuthnot Banking Group shares are held by institutional investors. 4.4% of Dr. Martens shares are held by insiders. Comparatively, 64.3% of Arbuthnot Banking Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Dr. Martens has higher revenue and earnings than Arbuthnot Banking Group. Arbuthnot Banking Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.
Arbuthnot Banking Group received 125 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 91.67% of users gave Dr. Martens an outperform vote while only 56.67% of users gave Arbuthnot Banking Group an outperform vote.
Summary
Dr. Martens beats Arbuthnot Banking Group on 10 of the 17 factors compared between the two stocks.
Get Arbuthnot Banking Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for ARBB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Arbuthnot Banking Group Competitors List
Related Companies and Tools
This page (LON:ARBB) was last updated on 4/19/2025 by MarketBeat.com Staff
Buy ARBB Stock Free ARBB Stock Alerts